Immunotherapy for Viral Infections and Malignancy
Transplantation-focused research has resulted in substantial new knowledge leading to revisions in patient eligibility, improved understanding of when transplant should and should not be applied, and supportive care strategies. In this session, clinicians will learn about upcoming clinical trials using cell therapy which may affect post-transplant care.
This activity is intended for hematologists/oncologists, transplant physicians and other health care professionals who treat patients with adult leukemia, myelodysplasia, lymphoma, and multiple myeloma.
Describe potential uses of cellular therapies to treat post-transplant complications
Helen Heslop, M.D.
Professor, Department of Pediatrics and Medicine
Director, Adult Bone Marrow and Stem Cell Transplant Program
Center for Cell and Gene Therapy at Baylor College of Medicine,
Methodist Hospital, and Texas Children's Hospital
If you have any questions regarding this activity, call Renee Ryan at (800) 526-7809 ext. 8430, or e-mail firstname.lastname@example.org